RMGP Biopharma Investment Fund is focused on early stage innovative therapies in areas of high unmet need. Through its partnership with OrbiMed, Johnson & Johnson and Takeda, RMGP provides an opportunity to invest in the cutting-edge portfolio of the FutuRx incubator. The RMGP Biopharma Investment Fund is managed by RM Global Healthcare Fund Management.